LEF1 and Alzheimer disease: Although TFBS were generally increased in the AD patient relative to the control in these loci (53 TFs), three TFs had a predicted decrease in binding sites in AD2 (KMT2A, LEF1, STAT5A), while 50 TFs had no TFBS predicted in these loci.